Pain is one of TetraQ’s areas of special expertise. TetraQ has experience with a number of pain target classes, molecule classes, dosing routes and has the ability to quantitatively assess several side effects in vivo.
TetraQ has more than thirteen Pain Models including sensitivity and perception, acute stimulus, chronic Inflammatory Pain, Neuropathic Pain, Bone Cancer Pain, Post-herpetic Neuralgia (post-shingles pain), Osteoarthritis and additional models are under development largely driven by industry’s needs.
TetraQ has formal partnerships with other preclinical CROs in order to offer clients a spectrum of pain studies in different species.
QUICK LINKS